Article Details

Halozyme Announces Roche Receives EC Approval For Phesgo® (Fixed-Dose Combination Of ...

Retrieved on: 2020-12-23 07:18:45

Tags for this article:

Click the tags to see associated articles and topics

Halozyme Announces Roche Receives EC Approval For Phesgo® (Fixed-Dose Combination Of .... View article details on hiswai:

Excerpt

... First Subcutaneous Fixed-dose Combination of Two Monoclonal Antibodies Approved in Europe Utilizing Halozyme's ENHANZE® Technology.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo